Nyxoah SA

NYXH

----

Current ValuationThe current P/E ratio is -0.35, above the reasonable range, cheaper than 0% of the time in the past 1 years, and the industry ranks 69/173, the industry Median -0.92.

-0.351xP/E

Stock price$0.90Earnings per share$-2.55

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-12.01x	140.96%	$12.77B
GKOSUSGlaukos	-55.47x	75.37%	$10.43B
TFXUSTeleflex	-5.36x	118.39%	$5.53B
ASSTUSStrive	-3.91x	63.23%	$3.81B
IRTCUSIRhythm	-268.37x	71.47%	$3.74B
PLSEUSPulse Biosciences	-45.71x	26.85%	$3.66B
AXGNUSAxogen	-63.80x	16.18%	$2.14B
BFLYUSButterfly Network	-25.26x	31.45%	$1.89B
NVCRUSNovocure	-12.22x	1.23%	$1.82B
ATECUSAlphatec	-15.25x	41.67%	$1.68B
KMTSUSKestra Medical Tech	-10.68x	0.79%	$1.60B
DRTSUSAlpha Tau Medical	-13.44x	--	$1.24B
ENOVUSEnovis	-1.09x	100.97%	$1.20B
TNDMUSTandem Diabetes	-17.97x	77.60%	$1.14B
AORTUSArtivion	-349.90x	266.67%	$1.12B
PRCTUSPROCEPT BioRobotics	-9.53x	3.47%	$1.05B
CBLLUSCeribell	-15.78x	35.15%	$1.04B
BBNXUSBeta Bionics	-13.27x	11.45%	$968.61M
QDELUSQuidelOrtho	-0.92x	75.33%	$965.54M
SIBNUSSI-BONE	-63.77x	8.85%	$933.12M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.